1Monji A, Kato T, Kanba S. Cytokines and schizophrenia: microglia hypothesis of schizophrenia [J].Psychiatry and Clinical Neuro- sciences ,2009,63 ( 3 ) :257-265.
2Gilmour G, Dix S, Fellini L, et al. NMDA receptors, cognition and schizophrenia-testing the validity of the NMDA receptor hypofunc- tion hypothesis [ J ]. Neuropharmacology,2012,62 ( 3 ) : 1401-1412.
3Ginovart N, Kaput S. Role of dopamine D2 receptors for antipsy- chotie activity[ M ]//Current Antipsychotics. Springer Berlin Hei- delberg,2012:27-52.
4Mulle JG. Schizophrenia genetics : progress, at last [ J ]. Current O- pinion in genetics & development,2012,22( 3 ) :238-244.
5Gupta S, Kulhara P. What is schizophrenia: A neurodevelopmental or neurodegenerative disorder or a combination of both? A critical analysis[ J ]. Indian Journal of Psychiatry ,2010,52:21.
6Rapeport JL, Giedd JN, Gogtay N. Neurodevelopmental model of schizophrenia: update 2012 [ J ]. Molecular psychiatry, 2012, 17 (12) : 1228-1238.
7Monji A, Kato T A, Mizognehi Y, et al. Neuroinflammation in schiz- ophrenia especially focused on the role of microglia [ J ]. Progress 1Neuro-Psycbopharmaeology Biological Psychiatry, 2013,42 ( 1 ) : 115-121.
85teiner J, Bogerts B, 5arnyai Z, et al. Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major de-pression: Potential role of glial NMDA receptor modulators and im- paired blood-brain barrier integrity[ J 1. World Journal of Biological Psychiatry ,2012,13 (7) :482-492.
9Zhu S, Stavrovskaya I G, Drozda M, et 81. Minocycline inhibits cy- tochrome c release and delays progression of amyotrophic lateral sclerosis in mice[J]. Nature,2002,417(6884) :74-78.
10Wang J, Wei Q, Wang CY, et al. Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria[ J ]. Journal of Bi- ological Chemistry,2004,279 (19) : 19948-19954.
